How Much Did Complion Raise?
Funding & Key Investors

Complion, a leading provider of eRegulatory solutions for clinical trial sites, has secured $12.2M in total funding, with its most recent financing round totaling $350K. This major strategic investment underscores the company's significant traction in streamlining regulatory document management for Sponsors and CROs across thousands of trials.

What is Complion?

Complion
SoftwareHealthcare SoftwareContent & Collaboration Software

Complion offers a cloud-based software platform designed to manage electronic regulatory files (eRegulatory) for clinical trial sites and electronic Investigator Site Files (eISF) for Sponsors and CROs. Founded by a clinical researcher, the company focuses on optimizing the handling of site regulatory documents and remote monitoring processes. Its purpose-built workflows automate the filing, sharing, signing, reviewing, and collection of essential documents, thereby eliminating redundant manual work and reducing errors. This enables efficient remote work and ensures timely access to critical information for study management and monitoring, benefiting over 14,000 trials.

How much funding has Complion raised?

Complion has raised a total of $12.2M across 4 funding rounds:

2015

Private Equity

$2M

2016

Series A

$2.9M

2019

Series B

$7M

2020

Debt

$350K

Private Equity (2015): $2M, investors not publicly disclosed

Series A (2016): $2.9M, investors not publicly disclosed

Series B (2019): $7M supported by Beringea , LLC.

Debt (2020): $350K featuring PPP

Key Investors in Complion

Beringea , LLC.

Beringea is an international venture capital firm that invests in high-growth businesses, focusing on empowering entrepreneurs to build significant companies. Their expertise spans multiple sectors, providing strategic support to portfolio companies.

What's next for Complion?

With substantial enterprise-level backing, Complion is well-positioned for continued expansion and innovation in the clinical trial technology sector. The company's focus on site-centric regulatory solutions addresses a critical pain point in clinical research, aiming to enhance efficiency and data quality. Future growth is likely to involve further development of its platform's capabilities, expanding its client base among Sponsors, CROs, and various healthcare institutions, and potentially exploring new market segments within the broader life sciences industry. The strategic nature of its recent capital infusion suggests a focus on scaling operations and solidifying its market leadership.

See full Complion company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Security SoftwareSoftware
Security SoftwareSoftware
Multimedia, Games & Graphics SoftwareSoftware
SoftwareSupply Chain Management (SCM) SoftwareBusiness Intelligence (BI) Software

Frequently Asked Questions Regarding Complion Financial Insights

What are the most recent funding rounds that Complion has completed, and what were the funding rounds?
Complion has recently completed 3 funding rounds: Debt on Apr 14, 2020, Series B on Feb 12, 2019, Series A on Jul 21, 2016.
What is the total amount of funding Complion has raised to date?
Complion has raised a total of $12.2M in funding to date.
How many funding rounds has Complion completed?
Complion has completed 3 funding rounds.
How much funding did Complion raise in its most recent funding round?
Complion raised $350K in its most recent funding round.
Who are the lead investors in Complion's latest funding round?
The lead investor in Complion's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Complion's history?
The largest funding round in Complion's history was $7M.
See more information about Complion